Key result
ESC STEMI registry evaluates contemporary reperfusion therapy use and one-year outcomes.
Why the study?
The registry aimed to evaluate the contemporary use of reperfusion therapy in ESC member and affiliated countries and assess adherence to ESC STEMI guidelines.
Observational (n=11,462)
Yes
The ESC ACCA-EAPCI EORP ACS STEMI registry is established to provide insights into the contemporary patient profile, management patterns, and 1-year outcomes of STEMI patients across 29 countries.
High STEMI reperfusion rates (>90%) yield low in-hospital mortality yet timely primary PCI varies widely by region; leaves open targeted network improvements.
AIMS: The Acute Cardiac Care Association (ACCA)-European Association of Percutaneous Coronary Intervention (EAPCI) Registry on ST-elevation myocardial infarction (STEMI) of the EurObservational programme (EORP) of the European Society of Cardiology (ESC) registry aimed to determine the current state of the use of reperfusion therapy in ESC member and ESC affiliated countries and the adherence to ESC STEMI guidelines in patients with STEMI. METHODS AND RESULTS: Between 1 January 2015 and 31 March 2018, a total of 11 462 patients admitted with an initial diagnosis of STEMI according to the 2012 ESC STEMI guidelines were enrolled. Individual patient data were collected across 196 centres and 29 countries. Among the centres, there were 136 percutaneous coronary intervention centres and 91 with cardiac surgery on-site. The majority of centres (129/196) were part of a STEMI network. The main objective of this study was to describe the demographic, clinical, and angiographic characteristics of patients with STEMI. Other objectives include to assess management patterns and in particular the current use of reperfusion therapies and to evaluate how recommendations of most recent STEMI European guidelines regarding reperfusion therapies and adjunctive pharmacological and non-pharmacological treatments are adopted in clinical practice and how their application can impact on patients' outcomes. Patients will be followed for 1 year after admission. CONCLUSION: The ESC ACCA-EAPCI EORP ACS STEMI registry is an international registry of care and outcomes of patients hospitalized with STEMI. It will provide insights into the contemporary patient profile, management patterns, and 1-year outcome of patients with STEMI.
No takes yet. Share an insight, caveat, or question.
Zeymer et al. (2019) conducted an observational in ST-elevation myocardial infarction (n=11,462). Reperfusion therapy was evaluated on Demographic, clinical, and angiographic characteristics, and management patterns. The ESC ACCA-EAPCI EORP ACS STEMI registry enrolled 11,462 patients across 196 centers in 29 countries to evaluate contemporary reperfusion therapy use and 1-year outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: